Firms

EcoR1 Capital

EcoR1 Capital

San Francisco, California, United States

San Francisco biotechnology investment advisory firm founded by Oleg Nodelman. It invests in companies across stages of research and development, combining scientific evaluation with investment analysis. Its published venture portfolio includes AI-enabled drug discovery, computational biotechnology, cell and gene therapies, and companies developing treatments for neurological disorders.

Founded
2013
Type
Venture capital

Funds0

No funds on record yet.

Team

Operations and support

Basheer ZadaBasheer ZadaPrincipal
Caroline ChoCaroline ChoExecutive Personal Assistant
Maddie GehrichMaddie GehrichInvestor Relations Associate
Miranda FornaroMiranda FornaroOperations Manager
Nima EmamiNima EmamiAnalyst
Oleg KhusainovOleg KhusainovController
Oleg NodelmanOleg NodelmanFounder and Portfolio Manager
Sarah MarriottSarah MarriottPartner, Chief Operating Officer, General Counsel and Chief Compliance Officer
Scott PerlenScott PerlenChief Financial Officer
Whan LeeWhan LeeSenior Analyst

Co-investing

Samsara BioCapital
Janus Henderson Investors
Redmile Group
Alexandria Venture Investments
Avidity Partners

Investments

$200M2026-02-17ImmunicBVF Partners L.P., Avidity Partners, EcoR1 Capital, Janus Henderson Investors, OrbiMed, RA Capital Management, Vivo Capital, Woodline Partners, Trails Edge Capital Partners
$30M2025-12-18CAMP4 TherapeuticsJanus Henderson Investors, EcoR1 Capital, Trails Edge Capital Partners, Vivo Capital
$200M2024-11-04NeurogeneRTW Investments, LP, Casdin Capital, EcoR1 Capital, Redmile Group, Commodore Capital, Samsara BioCapital, Great Point Partners
$95M2023-12-18NeurogeneEcoR1 Capital, Redmile Group, Samsara BioCapital, Janus Henderson Investors, BlackRock, Casdin Capital, Avidity Partners, Cormorant Asset Management, Alexandria Venture Investments, Great Point Partners
$150M2022-02-03Dewpoint TherapeuticsSoftBank Vision Fund 2, ARCH Venture Partners, Leaps by Bayer, Maverick Ventures, Mirae Asset Capital, General Catalyst, BECO Capital, 3E Bioventures Capital, NS Investment, Polaris Partners, Samsara BioCapital, Mubadala Capital, Elena Viboch, EcoR1 Capital
$115M2020-12-16NeurogeneEcoR1 Capital, Redmile Group, Samsara BioCapital, Cormorant Asset Management, BlackRock, Janus Henderson Investors, Casdin Capital, Avidity Partners, Alexandria Venture Investments
$77M2020-09-29Dewpoint TherapeuticsARCH Venture Partners, Maverick Ventures, Leaps by Bayer, Polaris Partners, Samsara BioCapital, Innovation Endeavors, EcoR1 Capital
$68M2019-02-12NeurogeneEcoR1 Capital, Samsara BioCapital, Cormorant Asset Management, Redmile Group
$60M2019-01-30Dewpoint TherapeuticsPolaris Partners, Samsara BioCapital, 6 Dimensions Capital, Alexandria Venture Investments, Leaps by Bayer, EcoR1 Capital
$—Unknown dateUnity BiotechnologyEcoR1 Capital